Annual Cost Of Goods Sold
$920.20 M
+$125.69 M+15.82%
December 31, 2022
Summary
- As of February 7, 2025, HZNP annual cost of goods sold is $920.20 million, with the most recent change of +$125.69 million (+15.82%) on December 31, 2022.
- During the last 3 years, HZNP annual cost of goods sold has risen by +$558.02 million (+154.08%).
Performance
HZNP Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cost Of Goods Sold
$219.96 M
+$11.39 M+5.46%
June 30, 2023
Summary
- As of February 7, 2025, HZNP quarterly cost of goods sold is $219.96 million, with the most recent change of +$11.39 million (+5.46%) on June 30, 2023.
- Over the past year, HZNP quarterly cost of goods sold has dropped by -$10.26 million (-4.46%).
Performance
HZNP Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Cost Of Goods Sold
$903.44 M
-$10.26 M-1.12%
June 30, 2023
Summary
- As of February 7, 2025, HZNP TTM cost of goods sold is $903.44 million, with the most recent change of -$10.26 million (-1.12%) on June 30, 2023.
- Over the past year, HZNP TTM cost of goods sold has dropped by -$34.99 million (-3.73%).
Performance
HZNP TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cost Of Goods Sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
HZNP Cost Of Goods Sold Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.8% | -4.5% | -3.7% |
| 3 y3 years | +154.1% | +81.0% | +123.7% |
| 5 y5 years | +86.5% | +140.8% | +149.4% |
HZNP Cost Of Goods Sold Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -13.7% | -8.9% | -5.2% | -3.7% | -12.1% |
| 5 y | 5-year | at high | -60.6% | -12.6% | -56.8% | -3.7% | -59.9% |
| alltime | all time | at high | -99.5% | -12.6% | -99.7% | -3.7% | -99.8% |
Horizon Therapeutics Public Limited Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $219.96 M(+5.5%) | $903.44 M(-1.1%) |
| Mar 2023 | - | $208.56 M(-13.4%) | $913.70 M(-0.7%) |
| Dec 2022 | $920.20 M(+15.8%) | $240.79 M(+2.8%) | $920.20 M(-0.1%) |
| Sep 2022 | - | $234.13 M(+1.7%) | $920.92 M(-1.9%) |
| Jun 2022 | - | $230.22 M(+7.0%) | $938.43 M(+3.2%) |
| Mar 2022 | - | $215.06 M(-11.0%) | $909.21 M(+14.4%) |
| Dec 2021 | $794.51 M(+49.1%) | $241.51 M(-4.0%) | $794.51 M(+11.1%) |
| Sep 2021 | - | $251.64 M(+25.2%) | $715.29 M(+16.3%) |
| Jun 2021 | - | $201.00 M(+100.3%) | $615.13 M(+14.8%) |
| Mar 2021 | - | $100.37 M(-38.2%) | $535.65 M(+0.6%) |
| Dec 2020 | $532.70 M(+47.1%) | $162.29 M(+7.1%) | $532.70 M(+14.5%) |
| Sep 2020 | - | $151.47 M(+24.7%) | $465.33 M(+15.2%) |
| Jun 2020 | - | $121.52 M(+24.7%) | $403.80 M(+8.7%) |
| Mar 2020 | - | $97.42 M(+2.6%) | $371.45 M(+2.6%) |
| Dec 2019 | $362.18 M(-7.4%) | $94.92 M(+5.5%) | $362.18 M(-1.0%) |
| Sep 2019 | - | $89.95 M(+0.9%) | $365.85 M(-0.3%) |
| Jun 2019 | - | $89.16 M(+1.2%) | $366.98 M(-0.6%) |
| Mar 2019 | - | $88.14 M(-10.6%) | $369.15 M(-5.7%) |
| Dec 2018 | $391.30 M(-20.7%) | $98.60 M(+8.3%) | $391.30 M(+0.0%) |
| Sep 2018 | - | $91.08 M(-0.3%) | $391.29 M(-8.1%) |
| Jun 2018 | - | $91.34 M(-17.2%) | $425.73 M(-8.4%) |
| Mar 2018 | - | $110.29 M(+11.9%) | $464.54 M(-5.8%) |
| Dec 2017 | $493.37 M(+25.9%) | $98.58 M(-21.5%) | $493.37 M(-9.2%) |
| Sep 2017 | - | $125.52 M(-3.6%) | $543.26 M(+8.0%) |
| Jun 2017 | - | $130.15 M(-6.4%) | $502.91 M(+10.8%) |
| Mar 2017 | - | $139.12 M(-6.3%) | $453.88 M(+15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $392.00 M(+78.6%) | $148.48 M(+74.4%) | $392.00 M(+26.0%) |
| Sep 2016 | - | $85.16 M(+5.0%) | $311.09 M(+8.3%) |
| Jun 2016 | - | $81.13 M(+5.0%) | $287.18 M(+7.2%) |
| Mar 2016 | - | $77.23 M(+14.3%) | $267.88 M(+22.0%) |
| Dec 2015 | $219.50 M(+178.7%) | $67.57 M(+10.3%) | $219.50 M(+18.9%) |
| Sep 2015 | - | $61.25 M(-0.9%) | $184.61 M(+34.7%) |
| Jun 2015 | - | $61.83 M(+114.3%) | $137.00 M(+37.0%) |
| Mar 2015 | - | $28.85 M(-11.7%) | $99.99 M(+27.0%) |
| Dec 2014 | $78.75 M(+438.5%) | $32.68 M(+139.5%) | $78.75 M(+53.4%) |
| Sep 2014 | - | $13.64 M(-45.0%) | $51.33 M(+25.5%) |
| Jun 2014 | - | $24.81 M(+225.6%) | $40.89 M(+121.3%) |
| Mar 2014 | - | $7.62 M(+45.0%) | $18.48 M(+26.3%) |
| Dec 2013 | $14.63 M(+23.2%) | $5.25 M(+63.9%) | $14.63 M(+16.9%) |
| Sep 2013 | - | $3.21 M(+34.0%) | $12.51 M(-4.6%) |
| Jun 2013 | - | $2.39 M(-36.5%) | $13.12 M(-3.4%) |
| Mar 2013 | - | $3.77 M(+19.9%) | $13.58 M(+14.3%) |
| Dec 2012 | $11.88 M(+63.4%) | $3.14 M(-17.5%) | $11.88 M(+9.9%) |
| Sep 2012 | - | $3.81 M(+33.5%) | $10.81 M(+31.1%) |
| Jun 2012 | - | $2.85 M(+38.1%) | $8.25 M(+10.0%) |
| Mar 2012 | - | $2.07 M(-0.4%) | $7.50 M(+3.1%) |
| Dec 2011 | $7.27 M(+70.5%) | $2.08 M(+66.2%) | $7.27 M(+10.4%) |
| Sep 2011 | - | $1.25 M(-40.6%) | $6.58 M(+8.4%) |
| Jun 2011 | - | $2.10 M(+14.4%) | $6.07 M(-0.5%) |
| Mar 2011 | - | $1.84 M(+32.0%) | $6.10 M(+43.1%) |
| Dec 2010 | $4.26 M | $1.39 M(+89.0%) | $4.26 M(+48.6%) |
| Sep 2010 | - | $737.00 K(-65.4%) | $2.87 M(+34.6%) |
| Jun 2010 | - | $2.13 M | $2.13 M |
FAQ
- What is Horizon Therapeutics Public Limited annual cost of goods sold?
- What is the all time high annual cost of goods sold for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual cost of goods sold year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly cost of goods sold year-on-year change?
- What is Horizon Therapeutics Public Limited TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited TTM cost of goods sold year-on-year change?
What is Horizon Therapeutics Public Limited annual cost of goods sold?
The current annual cost of goods sold of HZNP is $920.20 M
What is the all time high annual cost of goods sold for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual cost of goods sold is $920.20 M
What is Horizon Therapeutics Public Limited annual cost of goods sold year-on-year change?
Over the past year, HZNP annual cost of goods sold has changed by +$125.69 M (+15.82%)
What is Horizon Therapeutics Public Limited quarterly cost of goods sold?
The current quarterly cost of goods sold of HZNP is $219.96 M
What is the all time high quarterly cost of goods sold for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly cost of goods sold is $251.64 M
What is Horizon Therapeutics Public Limited quarterly cost of goods sold year-on-year change?
Over the past year, HZNP quarterly cost of goods sold has changed by -$10.26 M (-4.46%)
What is Horizon Therapeutics Public Limited TTM cost of goods sold?
The current TTM cost of goods sold of HZNP is $903.44 M
What is the all time high TTM cost of goods sold for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high TTM cost of goods sold is $938.43 M
What is Horizon Therapeutics Public Limited TTM cost of goods sold year-on-year change?
Over the past year, HZNP TTM cost of goods sold has changed by -$34.99 M (-3.73%)